# Drug-Drug Interaction Study Evaluating Effects of ASP015K on Rosuvastatin

> **NCT01959399** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Global Development, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Healthy Subjects
- Pharmacokinetics of ASP015K

## Interventions

- **DRUG:** ASP015K
- **DRUG:** Rosuvastatin

## Key facts

- **NCT ID:** NCT01959399
- **Lead sponsor:** Astellas Pharma Global Development, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01959399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01959399, "Drug-Drug Interaction Study Evaluating Effects of ASP015K on Rosuvastatin". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT01959399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*